Prostate cancer
Results
Phase 1
This study looked at a drug called AZD3514 for prostate cancer.
It was for men with prostate cancer that had spread to another part of the body and was no longer responding to hormone therapy.
Recruitment start: 23 August 2012
Recruitment end: 10 December 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr T. Elliott
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 05 Mar 2019
CRUK internal database number: 7214
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
